UTI & STI Testing
Promus Diagnostics’ comprehensive molecular UTI panel provides a complete set of data much faster than traditional urine culture — making results more relevant, meaningful and reliable.
Urinary Tract Infection
+ Antibiotic Resistance Genes (UTI+ABR)
Promus Diagnostics Molecular PCR UTI Test is the Solution
Urinary Tract Infections (UTI) are the most common bacterial infection among long term care residents and the second most common infection diagnosed in the acute hospital setting. UTIs account for almost 5% of all emergency department visits by adults aged 65 years and older in the United States each year.
Traditional testing for a UTI involves a urine culture which can take days to complete, greatly reducing sensitivity and accuracy. Without an accurate identification of the pathogen, healthcare providers may treat the patient with a course of antibiotics that may not be the optimal choice based on pathogens present resulting in persistent or recurring UTIs.
A recent study by Washington University found that of the 670,450 women tested, 46.7% “received antibiotic prescriptions for inappropriate agents” and 76.1% received antibiotics for an incorrect duration.1
At Promus Diagnostics we provide a better solution for identifying the pathogens causing an UTI using real-time PCR technology. Our UTI+ABR test panel can quickly and accurately identify 31 different infection causing pathogens and 22 antimicrobial resistance markers, giving healthcare providers the clearest and most robust information to develop a treatment regimen.
Identification where culture or dipstick may not have detected infection, or inconclusive due to sample contamination
Reduce or eliminate recurrent infections based on superior identification of Uropathogens for proper treatment
Informed drug selection to remediate infection, decrease incidents of adverse events as well as lessen the potential for antibiotic resistance
